Updated:
Hangzhou Diagens Biotechnology Co., Ltd.
No public founding date or named founder is available for Hangzhou Diagens Biotechnology Co., Ltd..
Hangzhou Diagens Biotechnology Co., Ltd.
No public founding date or named founder is available for Hangzhou Diagens Biotechnology Co., Ltd.. The firm operates as a manufacturer of in-vitro diagnostic products, including reagents and instruments for clinical chemistry, immunoassay, and molecular diagnostics, serving hospital and laboratory customers primarily in China's domestic market (per public record). The company's product portfolio spans routine biochemical assays, infectious disease testing, tumor markers, and thyroid function panels. It also provides fully automated analyzers and supporting software for lab workflow integration. Diagens markets its solutions to tier-2 and tier-3 hospitals in China and has reported exports to Southeast Asia and Africa (per public record). No team size, executive roster, or AUM figures are publicly available. The firm appears to be a privately held operating company, not a fund or family office. No philanthropic or adjacent investment vehicles have been identified. As a manufacturer of diagnostic products, Diagens' structural differentiator lies in its integrated approach: developing both reagents and instruments for a closed-system workflow, which is common among Chinese IVD firms seeking to reduce dependency on foreign suppliers. No succession or governance details are available.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hangzhou
Corporate office
Hangzhou, Zhejiang, China
Sector focus
Frequently asked questions
Who runs investment decisions at Hangzhou Diagens Biotechnology Co., Ltd.?
No executive leadership or investment decision-makers are identified in public records for this firm. It is an operating company, not a fund or family office, and does not appear to have an investment committee structure.
Is Hangzhou Diagens Biotechnology Co., Ltd. structured as a family office or an asset manager?
Public records indicate Hangzhou Diagens Biotechnology Co., Ltd. is a commercial diagnostics manufacturer, not a family office, asset manager, or investment vehicle. It produces and sells in-vitro diagnostic reagents and instruments.
What investment stages does Hangzhou Diagens Biotechnology Co., Ltd. typically target?
The firm does not function as an investment entity. It is an operating company manufacturing diagnostic products, and no investment stage targeting is publicly documented.
Which sectors does Hangzhou Diagens Biotechnology Co., Ltd. explicitly avoid?
No explicit sector avoidance has been disclosed. The firm's known activity is confined to the diagnostic and laboratory equipment sector within the healthcare industry.
Does Hangzhou Diagens Biotechnology Co., Ltd. maintain philanthropic structures?
No philanthropic vehicles or foundations linked to Hangzhou Diagens Biotechnology Co., Ltd. have been identified in public records.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: